Calpain B is one of the two calpain homologues in Drosophila melanogaster that are proteolytically active. We studied its activation by Ca 2+ both in vitro and in vivo, in Schneider (S2) cells. Activation involves the autolytic cleavage, at two major sites, of the N-terminal segment, the length of which was earlier underestimated. Site-directed mutagenesis at the autolytic sites did not prevent autolysis, but only shifted its sites. Calpain B mRNA was detectable in all developmental stages of the fly. In situ hybridization and immunostaining showed expression in ovaries, embryo and larvae, with high abundance in larval salivary glands. In S2 cells, calpain B was mainly in the cytoplasm and upon a rise in Ca 2+ the enzyme adhered to intracellular membranes.
INTRODUCTION
Members of the calpain superfamily pervade the Animal Kingdom, and they can also be found in lower eukaryotes (e.g. yeasts), and even in plants [1] [2] [3] . In mammals, the typical ubiquitous forms are Ca 2+ -activated, neutral thiol proteases residing in the cytoplasm in two isoforms: µ-and m-calpain, which need micromolar and millimolar Ca 2+ concentrations, respectively, for activation in vitro. Structurally, they are heterodimers consisting of a large (80 kDa) catalytic and a small (30 kDa) regulatory subunit [4, 5] . Whereas large subunits for µ-and mcalpains are different, they apparently share a common small subunit that plays a chaperone-like function [6] . Recently, a second small subunit has been described [7] ; its distribution and function are not known yet. Another regulator of ubiquitous calpains is the inhibitor protein calpastatin, also common in mammalian cells [8] .
In mammals, at least 14 genes code for calpain superfamily proteins. Many are structurally atypical and specific in their expression in one or a few tissues [2] . Mutations in these may lead to various pathological states [9, 10] . As for their mechanism of action, calpains as a rule carry out limited proteolysis on their target proteins, thereby altering their function. It is generally held that calpains are effectors in intracellular signal processing. It looks a formidable task to chart out all ramifications of calpain action.
It was workers in our laboratory who discovered calpains in the fruit fly Drosophila melanogaster [11, 12] . A partial clone with sequence homology to vertebrate calpains was found serendipitously [13] ; the full-length clone, coding for calpain A, was sequenced and the expression pattern of mRNA and protein in fly tissues studied. The second fly calpain homologue, calpain B, was assembled later from expressed sequence tag clones. Both were expressed in Escherichia coli, purified and characterized enzymologically [14] . According to the Drosophila genome database, there are two more genes in the fly genome that belong to the calpain superfamily: calpain C, an inactive homologue with all three active site residues mutated [15] , and calpain D, also called Abbreviations used: GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GFP, green fluorescent protein; RT-PCR, reverse transcriptase PCR. 1 To whom correspondence should be addressed (e-mail friedric@enzim.hu).
Sol, which was characterized earlier [16] but not demonstrated to be a Ca 2+ -activated protease. In the present study we examined calpain B in more detail: its autolytic activation both in vitro and in vivo, its mRNA level and expression pattern from ovary to larval stages. Studying the distribution of endogenous calpain B and GFP (green fluorescent protein)-tagged overexpressed calpain B in Schneider (S2) cells, we found intriguing differences in their intracellular localization.
EXPERIMENTAL

Materials
Restriction enzymes were purchased from New England Biolabs. The pET 22b expression vector and E. coli BL21(DE3) cells were obtained from Novagen. Ni 2+ -nitrilotriacetate resin was purchased from Qiagen. Drosophila Schneider cells and all reagents for maintaining them were purchased from Invitrogen. Calpain clones LD16770 and LD17211 were obtained from the BDGP (Berkley Drosophila Genome Project), Berkeley, CA, U.S.A. All other chemicals were from Sigma.
Construction of expression vectors
The CalpainB-pET22b construct encoding full-length calpain B was made by cloning the newly recognized N-terminal sequence into our previous incomplete clone [14] in frame by PCR from LD16770. The construct encoding the autolysed calpain B (AuCalpainBpET22b) was made with PCR from LD16770. Inactive calpain B (active-site mutant Cys 314 → Ala 314 ) was cloned into both the expression vector pET22b (ICalpainBpET22b) and the Drosophila transfection vector pRmeGFP on either the Nor C-terminus of GFP (ICalpainBC/NGFP). (Construction of the Drosophila transfection vector pRmeGFP was carried out through the modification of the pRm-Ha3 vector. Ha3 was replaced with the GFP coding sequence with multiple cloning sites on both ends.) The latter construct produces calpain B with a C-/Nterminal GFP under the control of a metallothionein promoter.
Site-directed mutagenesis
The calpain B active-site mutant was made with the megaprimer method [17] with the following primer: 5 -CAGTAGCCAGG-CTTCGCCAAG-3 . Calpain B autolysis sites were mutated with the QuikChange Site Directed Mutagenesis Kit from Stratagene following the instructions of the manufacturer. The primers were the following: 5 -CGAGTCATGCCGGTGTTCCGTCGTATGC-GGGAC-3 and 5 -GTCCCGCATACGACGGAACACCGGCA-TGACTCG-3 for the first major site; 5 -GAAGGTGCCCGA-GGCTGTTAACATGTTTTGG-3 and 5 -CAAAACATGTTAA-CAGCCTCGGGCACCTTC-3 for the second major site.
Expression of recombinant calpain B proteins in E. coli
The BL21(DE3) strain was transformed with the expression vectors using conventional techniques. Cells were grown in NZYM medium containing carbenicillin (50 µg/ml) at 37
• C, 250 rev./ min, until D 600 = 0.5-0.7. Expression was induced at 22
• C for 3 h by 0.05 mM IPTG (isopropyl β-D-thiogalactoside). The culture was cooled on ice and centrifuged at 3000 g for 10 min at 4
• C. Cells were suspended in 50 mM NaH 2 PO 4 /Na 2 HPO 4 , pH 7.5, 1 M NaCl, 5 mM EDTA, 1 % Tween 20, 2 % glycerol, 20 mM imidazole, 1 mM PMSF, 5 mM benzamidine and 20 mM 2-mercaptoethanol (suspension buffer), and sonicated for 6 × 15 s at 16 µm (MSE sonicator) on ice. The lysate was centrifuged at 100 000 g for 30 min at 4
• C. The supernatant was applied to a Ni 2+ -nitrilotriacetate-agarose column after the addition of MgCl 2 to a final concentration of 5 mM. After washing with 10 column vol. of washing buffer (suspension buffer without EDTA), calpain was eluted with a step gradient of washing buffer containing 40, 60, 80 and finally 250 mM imidazole.
Fluorometric assay
Calpain activity was measured in a continuous fluorometric assay in a Jasco FP 777 spectrofluorometer. The cleavage of the fluorescent substrate, N-succinyl-Leu-Tyr-7-amino-4-methylcoumarin (Sigma), was monitored at excitation and emission wavelengths of 380 and 460 nm, respectively. Reaction mixtures were made up in a final volume of 50 µl at room temperature in calpain buffer (10 mM Hepes, pH 7.5, 150 mM NaCl and 1 mM EDTA). Calpains were added in a final concentration of 0.3 mg/ ml, substrate was 1 mM. The reaction was started by the addition of CaCl 2 .
Maintaining Drosophila
Flies were maintained in 50 ml flasks on the following medium: 1.5 % agar, 6.6 % cornmeal, 9 % sugar, 6.6 % yeast, 9.2 mM NaCl, 3.4 mM CaCl 2 , 0.053 % phosphoric acid and 0.53 % propionic acid.
RNA preparation
Drosophila eggs, first-, second-and third-stage larvae, early and late pupae and adults were harvested from Drosophila culture. Total RNA to be used for reverse transcription and RT-PCR (reverse transcriptase PCR) was prepared with Trizol reagent (Invitrogen) according to the manufacturer's instructions and assayed by conventional methods. Two different fragments of the calpain B open reading frame (calpain B I and II) were amplified by PCR with two different sets of primers (forward, ATGTACGGCCATTGATAATTACC, and reverse, CTGGTTC-TCGGGCACCTTC; forward, ATGTACGGCCATTGATAAT-TACC, and reverse, AGTCTAGATCCGGTCGTCGTGAGTA-CATC; 27 cycles). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a control.
Antibody production against calpain B
Purified calpain B was used to immunize rabbits for polyclonal antibody production. The sera were used directly for immunoblotting without affinity purification. The antibody was checked to be specific for calpain B by immunoblot against recombinant calpain A and B.
RNA in situ hybridization
Digoxigenin-labelled DNA probe was synthesized by the Dig DNA labelling kit (Boehringer Mannheim) from purified calpain B cDNA. The hybridization was carried out as described in [18] . Hybridization signals were developed by the Dig Detection kit (Boehringer Mannheim) and visualized by interference contrast microscopy (Zeiss Axioscope II).
Detection of proteins in whole mount
Bleach-dechorionated embryos and dissected ovaries were collected in PBS (10 mM PBS/138 mM NaCl/2.7 mM KCl, pH 7.4). Ovaries were fixed for 10 min in a mixture of 1 vol. of fixation buffer (100 mM KH 2 PO 4 , pH 6.8, 450 mM KCl, 150 mM NaCl and 20 mM MgCl 2 ), 3 vol. of distilled water and 2 vol. of 16 % formaldehyde. Embryos were fixed for 12 min in a mixture of 1 vol. of fixation buffer (100 mM Pipes, pH 6.8, 2 mM MgSO 4 and 1 mM EGTA), 1/10 vol. of 37 % formaldehyde and 1 vol. of heptane. The aqueous phase was removed and 1 vol. of methanol was added. Ovaries and devitellinized embryos were washed in phosphate-buffered Tris for 2 × 20 min and blocked for 1 h in blocking solution (PBS plus 0.1 % BSA, 0.1 % Triton X-100, 5 % normal goat serum and 0.02 % NaN 3 ). Ovaries and embryos were then incubated overnight with anti-calpain B rabbit primary antibody diluted 1:500 in blocking solution, followed by 4 × 30 min washes in phosphate-buffered Tris and a 1 h wash in blocking solution. Final incubation was with a fluorescein-conjugated anti-rabbit secondary antibody diluted 1:200 (Jackson ImmunoResearch Laboratories) in blocking solution for 2 h. Ovaries and embryos were washed again 4 × 30 min in phosphate-buffered Tris, mounted in 80 % glycerol and 4 % n-propyl-gallate. The embryos were analysed using a Zeiss Axioscope II microscope equipped with an Axiocam CCD camera.
Schneider (S2) cells
Cells were cultured in serum-free medium supplemented with 20 mM L-glutamine, 50 units/ml penicillin and 50 µg/ml streptomycin at 24
• C. For visualizing vesicles cells were incubated with 50 µM BODIPY-3823 (Molecular Probes) for 1 min at 24
• C. For stable transfection of S2 cells the ICalpainBC/NGFP vectors were co-transfected with a Bluescript puromycin vector in the presence of Cellfectin reagent (Invitrogen) following the instructions of the manufacturer. The stable cell line was reached after five passages. The puromycin concentration was 50 µg/ml. Stably transfected cells expressing calpain B GFP were seeded on to glass coverslips in growth medium and induced with 0.7 mM CuSO 4 for 6 h in serum-free medium containing puromycin. The induction medium was changed to PBS or PBS supplemented with 10 µM ionomycin for a maximum of 30 min. Cells were washed in PBS then fixed in 3 % paraformaldehyde for 10 min. When using antibodies, cells were permeabilized with 0.1 % Triton-X 100, blocked for 30 min in 1 % BSA, incubated for 30 min with CalpB antibody (1000× in 1 % BSA), washed three times in PBS for 2 h, incubated in secondary antibody Rhodamine Red TM -X (Molecular Probes; 4 µg/ml in 1 % BSA) then washed for 2 h in PBS. Cells were mounted with MOWIOL 4-88 (Calbiochem) supplemented with DAPI and analysed by a Leica DMLS fluorescent microscope equipped with a Spot RT colour digital camera (Diagnostic Instruments).
Other methods SDS/PAGE was carried out as described in [19] . Immunoblotting was as in [20] . For N-terminal sequence analysis samples were run on SDS/PAGE gels and blotted on to PVDF membranes (Sigma). Sequence analysis was performed using a modifiedEdman-degradation sequencer program.
RESULTS
Sequence of full-length Drosophila calpain B
Earlier we proposed an amino acid sequence for calpain B [14] assembled from the clones available at that time. The first ATG was taken as the initiation codon, though it could not be excluded that the protein had more amino acids towards the N-terminus. As further overlapping clones (LD 16 770, LD 17 211) were sequenced in the Drosophila Genome Project, it became evident that the N-terminal segment of the protein is longer than we earlier presumed: it contains a 134 amino acid in-frame sequence upstream from the earlier starting Met (Figure 1 ). Thus the full length of the enzyme is 925 amino acids with a calculated molecular mass of 104 kDa. This size for calpain B was corroborated by an SDS/PAGE immunoblot run on a fresh fly extract and developed with anti-calpain B antibodies: only a single band at about 104 kDa could be seen (results not shown). The complete sequence has been deposited in the Entrez database under accession number AF062404.
Autolysis of calpain B
Stimulation of the enzyme with Ca 2+ in vitro, by adding Ca 2+ to the enzyme solution, or in vivo, by adding ionophore to S2 cells, results in similar autolytic conversion from 104 into 81 kDa, with intermediary fragments (Figure 2 ). The two major products of autolysis appear at 96 and 81 kDa. N-terminal sequencing identified the cleavage sites of the 96 and 81 kDa products: at QN 74 ↓ASY and NQ 224 ↓NMF, respectively (see Figure 1 ). The latter site is the same as found earlier with the truncated (91 kDa) calpain B [14] . The two minor fragments at about 92 and 88 kDa are much weaker, yet consistently found. Autolysis is apparently an intermolecular reaction, as in the mixture of active and inactive calpain B in a 1:10 molar ratio all enzyme protein became autolysed in the presence of Ca 2+ (results not shown).
Activation of calpain B
Addition of Ca 2+ induced enzyme activity in calpain B, which was continuously monitored by the cleavage of a fluorescent substrate (Figure 3 ). With recombinant calpain B there was a lag phase in the progress curve (transit time), to attain the linear steady-state reaction velocity later (Figure 3, curve A) . In contrast, with the recombinant autolysed enzyme (calpain B 1-224) the progress curve was linear right from the start (Figure 3, curve B) . These kinetic data suggest that intact calpain B is inactive and becomes activated during the lag phase. Further, the activation process apparently consists in the slow autolytic removal of the N-terminal segment and a fast Ca 2+ -induced conformational change. To check the necessity of autolysis for activation, we tried to interfere with autolysis of calpain B. Amino acids were replaced, by site-directed mutagenesis, on one or both sides of the two major autolytic sites with amino acids not accepted by calpains at the cleavage site. These amino acids were selected by a statistical analysis of calpain cleavage sites (P. Tompa, P. Buzder Lantos, A. Tantos, A. Farkas, A. Szilágyi, Z. Bánóczi, F. Hudecz and P. Friedrich, unpublished work). The following changes were SDS/PAGE patterns of autolysis. Calpain B (control), two major autolytic fragments at 96 and 81 kDa (arrows) (see Figure 2A) Figure 1 ). These modified calpain B forms were expressed in E. coli, purified and tested for Ca 2+ -induced autolysis (Figure 4) . The results were unexpected: autolysis was not arrested by these mutations, but its site shifted to new, nearby peptide bonds. In the case of the site between Q 224 and N 225 , two new sites emerged: one at F 215 ↓T 216 and one at G 230 ↓R 231 , as identified by N-terminal sequencing. In the case of site between N 74 and A 75 , modification gave rise to low-intensity, blurred band(s) which could not be analysed by sequencing. That these new sites were more sluggish than the original ones is shown by the activation time course (Figure 3 , curve C): the activation lag phase with the 'autolysis mutant' was longer than with wild-type calpain B.
Calpain B expression during fly development
Total RNA was prepared from all developmental stages of the fruit fly. RT-PCR was carried out on synthesized cDNA with two different primer sets for calpain B ( Figure 5 ). The level of calpain B message, normalized to GAPDH, was highest in the egg, which is presumably of maternal origin. In the early larval stage the level was very low, apparently as a result of degradation of maternal RNA. After this stage the level rose strongly, indicating the vigorous transcription of the CalpB gene up to the third larval stage, then the level became constant in the pupa and imago. The protein level ran almost parallel with mRNA, as detected by immunoblotting ( Figure 5) .
We studied the tissue expression pattern of the CalpB gene by in situ hybridization and protein immunostaining. In larval differentiation, expression varied in intensity for the different organs. Calpain B was strongly detectable in follicular and border cells of the oocyte (Figures 6A and 6B ). Calpain B mRNA was evenly distributed in early embryos ( Figure 6C ). In late embryos, the tracheas and their orifices, as well as the larynx, stained both for mRNA ( Figure 6E ) and protein ( Figures 6D and 6F ). In the third larval stage only the salivary gland gave a strong signal for mRNA and protein ( Figure 6G and 6H) .
Localization of calpain B in S2 cells
We studied the localization of calpain B in Schneider (S2) cells, at resting and elevated cytoplasmic Ca 2+ level; the latter was produced by 10 µM ionomycin. The distribution of both endogenous calpain B and calpain B overexpressed in the cells by stable transfection was examined.
Endogenous calpain B is evenly distributed in the cytoplasm, but not in the nucleus ( Figure 7A ). Upon a Ca 2+ increase, the In (A), the cytoplasm is evenly stained, the nucleus is not stained; in (B), the rise in Ca 2+ produces patches of calpain B (arrows), the nucleus remains unstained. (C) Nuclear (DAPI) and general membrane marker (BODIPY 500/510) immunostaining of a control cell: the nucleus is blue, vesicles are green. (D) Triple staining for nucleus, calpain B and vesicles, after ionomycin treatment. Vesicles that are yellow (arrows) bind calpain B, green ones do not, which points to specific membrane translocation. (E, F) GFP-fused, overexpressed calpain B without (E) and with (F) 10 µM ionomycin. In (F), the enzyme conjugate pervaded the nucleus, but not the nucleolus, and patchwise enzyme adherences to membranes are also discernible (arrows).
enzyme forms patches, possibly on intracellular membranous structures ( Figure 7B ). Indeed, calpain B immunoreactivity colocalized with some, but not all, vesicles ( Figures 7C and 7D) . Calpain B overexpressed in S2 cells was an inactive (Cys 135 → Ala 135 ) construct, to avoid uncontrolled autolysis and self-degradation, with GFP fused either to the N-or the C-terminal end. At low Ca 2+ concentrations these species were found in the cytoplasm, but not in the nucleus ( Figure 7E ). However, upon a Ca 2+ increase the GFP-containing enzyme forms seemed to penetrate the nucleus (Figure 7F ), in addition to patch-wise adherence to internal membranes.
DISCUSSION
In this work we corrected and extended our knowledge about calpain B, which besides calpain A described earlier [13] , is the other enzymically active Ca 2+ -dependent protease in Drosophila resembling in domain structure the typical mammalian calpains. We turned our attention also to the behaviour of the enzyme in vivo, i.e. in cultured Schneider (S2) cells, a cell line derived from Drosophila.
The total length of calpain B was revised. Namely, completion of the Drosophila Genome Project revealed further sequences pertinent to calpain B: one of them added 134 amino acids to the former N-terminus [14] . Thus the length of this 'tail', from the autolytic site at residue 701, is 224 amino acids. The novel N-terminal segment has an unusual amino acid composition and sequence: it contains 22 % proline and nine repeats of the PYP motif. This segment probably has no well-defined threedimensional structure, it belongs to the recently recognized class of intrinsically unstructured proteins [21] . As Pro-rich segments are thought to act as environmental sensors [22] , we assume that this exceptionally long N-terminal tail serves, among others, interactions with various cellular components.
The relationship between Ca 2+ -induced autolysis and activation seems clear with calpain B: activation requires autolysis. During activation of mammalian µ-and m-calpains by Ca 2+ , autolysis occurs at the N-termini of both large and small subunits [23] [24] [25] . There is no consensus about the mechanistic role of these autolyses: some authors regard them as consequences of activation [6, 26] , while others hold that they are essential for activation; at least, this is strongly suggested by the close parallelism between the amount of autolysed protein and enzyme activity in the case of µ-calpain [27] . Whatever holds true for mammalian calpains, it should be remembered that their domain I is very short compared with that of calpain B. The extremely long (224 amino acids) Nterminal segment of calpain B, with nine PYP motifs and a highly flexible structure [22] , may wind around the globular body of the enzyme, filling the active-site cleft and compromising activation.
With rat m-calpain the large subunit autolytic cleavage site (Ala 9 ↓Lys 10 ), when properly mutated, failed to get autolysed, yet the enzyme was active, proving that the intact large subunit is catalytically competent [26] . With this approach we could not check whether the intact calpain B was active or not. The 'mobility' of the autolytic sites, however, indicates that the intact polypeptide chain of calpain B cannot exist in the presence of Ca 2+ . The autolytic site 'immobility' with m-calpain as opposed to 'mobility' in calpain B, may stem from the large difference between the lengths of the two domains I: the mere 9 amino acid segment available in m-calpain may not give another chance to the enzyme.
It should be recalled that, in Drosophila, calpains have no small subunit and there is no calpastatin-like inhibitor. The small subunit in mammals serves a chaperone-like function in the folding of the large subunit [6, 7] . Such a function is apparently not needed for calpain B or at least it is not provided by the N-terminal part, which is proved by the equal activity yields of calpain B and fully autolysed calpain B when expressed in E. coli (results not shown).
A putative inhibitor of calpain A and B may be calpain C, recently described by us [15] . This calpain homologue in Drosophila is similar to calpain A and B: in domains II and III the sequence identity with calpain B is 30 and 35 %, respectively. However, in calpain C all three active-site residues, Cys, His and Asn, have been mutated. Accordingly, this protein cannot have calpain-like protease activity. On the other hand, it may serve as a dominant-negative effector for calpain A and B, e.g. by inhibiting these via dimerization or by occupying functional binding/targeting sites in the cell.
The calpain B mRNA and protein are present all through development, with a characteristic minimum in the early larval stage. The protein is particularly abundant in oocyte development: in the follicle cells and border cell. The latter migrate from the anterior pole among the nurse cells to the border of the forming egg, thereby offering a readily monitored model of cell motility and the role of calpain(s) therein. A great number of observations on mammalian systems support the assumption that calpains are instrumental in the processes of cell motility and migration [28] .
Calpain B indigenous in S2 cells is evenly distributed in the cytoplasm, as revealed by fluorescence microscopy. Upon a rise in cytoplasmic Ca 2+ level, it undergoes autolysis and adheres to intracellular membranes. In S2 cells stably transfected with inactive (Cys 135 → Ala 135 ) calpain B with a GFP tag fused to the Nor C-terminus, the overexpressed enzyme is again in the cytoplasm at resting Ca 2+ level. When Ca 2+ becomes elevated, however, the enzyme conjugates appear to enter the nucleus. This intriguing observation may be due to the GFP-tagged large enzyme pool produced by overexpression. GFP has been successfully used in a great number of studies in which it apparently did not influence the behaviour of the carrier protein [29] . On the other hand, GFP is highly soluble [30] , thus it may favour aqueous niches, such as the flexible and dilatable nuclear pore channel [31] . In fact, mammalian µ-calpain was shown to undergo ATP-dependent nuclear translocation [32] . In the case of calpain B, however, nuclear translocation upon a Ca 2+ increase seems to be an artefact which does not occur at normal cellular levels of the untagged enzyme.
Understanding the organization and functions of the Drosophila calpain system will pave the way to solving the more demanding case of the human system. 
